FDA authorizes Novavax's Covid vaccine

Norge Nyheter Nyheter

FDA authorizes Novavax's Covid vaccine
Norge Siste Nytt,Norge Overskrifter
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Novavax’s vaccine uses an older technology found in other widely used shots, offering people an alternative to the mRNA-based Pfizer and Moderna vaccines.

Novavax’s protein-based Covid vaccine for adults, providing Americans with an alternative to the mRNA-based shots from Pfizer-BioNTech and Moderna.Full coverage of the coronavirus outbreak

The FDA’s signoff isn’t the last step: The decision will now to go the Centers for Disease Control and Prevention and its advisory committee to issue their own recommendation on how the shots should be used. The CDC’s Advisory Committee on Immunization Practices is scheduled toThe U.S. has secured 3.2 million doses of the vaccine, ready to be shipped to states once it receives the green light, the Biden administration announced Monday.

The shot has already been cleared for use in more than 40 countries, as well as the European Union, but manufacturing problems have hampered the company's efforts to be authorized in the U.S.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NBCNewsHealth /  🏆 707. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Novavax COVID-19 vaccine: FDA authorizes fourth shot for adultsNovavax COVID-19 vaccine: FDA authorizes fourth shot for adultsNovavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the U.S. -- and one that’s already available in Europe and multiple other countries.
Les mer »

Novavax Covid-19 vaccine wins FDA authorizationNovavax Covid-19 vaccine wins FDA authorizationThe FDA granted emergency use authorization to Novavax’s Covid-19 vaccine. In a trial of more than 26,000 adults, 2 doses of the Novavax Covid vaccine were over 90% effective at preventing symptomatic disease and presented no serious side effects.
Les mer »

FDA Authorizes Novavax’s Covid-19 VaccineFDA Authorizes Novavax’s Covid-19 VaccineThe FDA has cleared use of Novavax’s Covid-19 vaccine, which uses an older technology that some people hesitant to get inoculated might be willing to get.
Les mer »

FDA gives emergency use authorization to Novavax's Covid-19 vaccineFDA gives emergency use authorization to Novavax's Covid-19 vaccineFDA gives emergency use authorization to Novavax's Covid-19 vaccine, which uses different technology than shots already available in US.
Les mer »

FDA Authorizes Novavax Covid Vaccine for Adults as the First New Shots in U.S. in More Than a YearFDA Authorizes Novavax Covid Vaccine for Adults as the First New Shots in U.S. in More Than a YearFDA authorization of Novavax’s vaccine was delayed for weeks as the agency reviewed changes to the company’s manufacturing process.
Les mer »



Render Time: 2025-03-12 20:30:33